Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity.

Eur J Nucl Med Mol Imaging · 2008 · PMC2668584 · PMID 18183394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

2 c) showed a trend towards a higher myocardial uptake over time (negative myocardial washout) for nca 123 I-MIBG (ca 123 I-MIBG = −10.85 ± 4.40% vs nca 123 I-MIBG = −18.04 ± 4.31%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.